Applications of 4,5-Dibromo-1-Methyl-1H-Imidazole in Industrial Manufacturing

4,5-Dibromo-1-Methyl-1H-Imidazole serves as a controlled intermediate for advanced synthesis in specialized chemical sectors. As a manufacturer, we supply this material to defined downstream industries where precision in compliance, ratio selection, and integration with proprietary processes is mission-critical. Below are key end-use scenarios based on actual industrial demand and regulatory practice.

1. Pharmaceutical Intermediate for Antiviral Drug Synthesis

Pharmaceutical companies use 4,5-Dibromo-1-Methyl-1H-Imidazole as a starting material for constructing imidazole-linked scaffolds in certain second- and third-generation antiviral actives. This compound is specifically valued for its bromination profile, enabling selective nucleophilic substitution steps that minimize unwanted side reactions. Dosage determination depends on stoichiometry with the co-reactant and required purity in the target intermediate. This material must meet stringent traceability and batch consistency requirements due to its introduction early in the synthesis pathway.

Industry compliance standards

• ICH Q7 Good Manufacturing Practices for Active Pharmaceutical Ingredients
• USP General Chapter <1790> Residual Solvents
• 21 CFR Part 211 CGMP for Finished Pharmaceuticals
• European Directorate for the Quality of Medicines (EDQM) guidelines for intermediates

Typical usage ratio

• Generally 0.85–1.1 equivalents relative to core nucleophile; adjusted to control bromide exchange and impurity formation during condensation steps

Downstream process integration

• Added during early-stage condensation or cyclization as the key halogenated reagent
• Integrated into multi-step, batch or continuous synthesis schemes
• Subject to in-line monitoring for residual reactants and byproducts
• Usually removed or transformed before final API crystallization

Final product types

• Antiviral API intermediates
• Specialty imidazole derivatives for prodrug APIs
• Reference standards for process validation
• Non-clinical development samples for regulatory submission

2. Building Block for Agrochemical Synthesis

Synthetic crop protection research incorporates 4,5-Dibromo-1-Methyl-1H-Imidazole as a reactive core for developing new fungicide molecules. This molecule enables targeted halogen exchange and ring modification, crucial for developing next-generation triazole fungicides. Our product supports batch-to-batch reproducibility and downstream scalability for multinational agrochemical formulators. Applied in regulated pilot and full-scale commercial settings, its use is tightly governed by environmental residue and occupational safety rules.

Industry compliance standards

• FAO/WHO specification for agrochemical raw materials
• ISO 9001:2015 Quality Management Systems
• REACH Regulation EC 1907/2006 for registration and safe use
• OECD Guidelines for the Testing of Chemicals

Typical usage ratio

• Used at 1.0 equivalent relative to metalation agent for bromide displacement; range: 0.95–1.2 equivalents based on yield optimization protocol

Downstream process integration

• Charged with base/solvent in heterocyclic ring substitution steps
• Subsequent processing includes workup, extraction, and conversion to key pesticide intermediates
• Extensive in-process control for bromine content and purity
• Fully documented in batch records as per regulatory dossier submission

Final product types

• Fungicide active ingredient precursors
• Advanced pesticide actives
• Stabilized triazole derivatives and adjuvants
• Plant protection research compounds

3. Advanced Material Precursor for Electronic and Photonic Applications

The compound sees adoption in specialty advanced materials synthesis, serving as a brominated heterocyclic precursor for high-performance organic semiconductors and photoactive materials. End-use companies leverage its structural selectivity to introduce brominated sites during polymer backbone assembly, impacting electronic characteristics for OLEDs, OFETs, and organic solar cells. Processing requires assurance of ultra-high purity and consistent bromination patterns, with defined integration points aligned to proprietary device recipes.

Industry compliance standards

• IEC 60747 series standards for semiconductor devices
• IPC-4101 for base materials in printed circuit applications
• ISO 14001 Environmental Management for electronic manufacturing sites
• RoHS Directive 2011/65/EU on hazardous substance restrictions

Typical usage ratio

• Typically 0.95–1.05 equivalents in copolymerization or cross-coupling synthesis; application-specific and optimized for targeted device performance

Downstream process integration

• Dosed during Suzuki, Stille, or Buchwald-Hartwig coupling to assemble π-conjugated chains
• Requires rigorous purification as part of pre-polymer feedstock blending
• Processed under inert conditions to prevent contamination
• Subject to QC verification for residual bromide and trace contaminants

Final product types

• Organic light-emitting diode (OLED) front-plane materials
• Semiconducting polymers for OFET fabrication
• Small molecule electron transport materials
• Photovoltaic active layer compounds for OPV devices

4. Reagent for Specialty Chemical Custom Synthesis

Custom synthesis providers and contract manufacturers use this material to introduce controlled bromination into diverse heterocyclic products. This compound enables selectivity in functionalization steps leading to pharmaceutical, diagnostic, and analytical reference materials. Customers rely on precise input ratios and validated addition sequences to achieve bespoke molecules with minimal side product formation, supporting late-stage lead optimization and formulation pipelines within regulated environments.

Industry compliance standards

• ISO 9001:2015 Quality Management System (custom synthesis QA/QC requirements)
• GMP or cGMP alignment where output feeds pharmaceutical applications
• GLP (Good Laboratory Practice) for analytical intermediates
• Hazardous Chemicals Registration and Control (local jurisdiction compliance)

Typical usage ratio

• Customized between 0.8–1.2 equivalents in stepwise additions, depending on molar excess strategy and target molecule complexity

Downstream process integration

• Introduced during halogenation, alkylation, or N-derivatization of advanced intermediates
• Integration point determined by retrosynthetic planning
• Used with monitored quench, extraction, and post-treatment cycles
• Material traceability maintained throughout batch paperwork

Final product types

• Custom pharmaceutical and diagnostic intermediates
• Analytical reference standards
• Fine chemical reagents for R&D kits
• Structural analog validation samples